A Phase 2, Open-label, Safety, Tolerability, and Efficacy Trial of a Botanical Drug at One Dose Level for the Treatment of External Condylomata Acuminata (Genital Warts) in Adult Immunocompetent Subjects
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Santalum album (Primary)
- Indications Condylomata acuminata
- Focus Adverse reactions
- Sponsors Santalis Healthcare Corporation
- 23 Oct 2017 Planned End Date changed from 1 Jan 2018 to 1 Mar 2018.
- 23 Oct 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Jan 2018.
- 23 Oct 2017 Status changed from not yet recruiting to recruiting.